Login to Your Account

Other News To Note

Monday, March 21, 2011
Quest Diagnostics Inc., of Madison, N.J., agreed to acquire Celera Corp., of Alameda, Calif., for $8 per share, or about $344 million, net of $327 million in acquired cash and short-term investments. The deal is expected to bolster Quest's molecular diagnostics work and add a pipeline of biomarkers for future development.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription